comparemela.com
  1. Home
  2. Live Updates
  3. Concentra Biosciences - Breaking News

Latest Breaking News On - Concentra biosciences - Page 1 : comparemela.com

LianBio to shut down, return cash to investors

BioPharma

Concentra biosciencesMichael yeeBristol myers squibbDive briefTang capitalPerceptive advisors

LianBio Shares Gain After Co Announces Plans to Wind Down

By Mary de Wet LianBio shares were up nearly 17% in premarket trading Tuesday after the troubled biotechnology company said it would wind down its.

United statesConcentra biosciencesAmerican depositary sharesNasdaq global marketMary de wetArticle normalBiotechnology servicesHealthcare life sciencesCorporate strategy planningFinancial performanceCorporate industrial newsContent typesFactiva filtersC amp ampe industry news filterCorporate strategyIndustrial news

Princeton biotech to wind down operations

Princeton biotech to wind down operations
njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.

South koreaYi larsonYizhe wangKonstantin poukalovConcentra biosciencesAmerican depositary sharesNasdaq globalJanssen pharmaceuticaNew brunswick based johnsonChief financial officer yi larson

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - AMAM, TGAN, CSTR, THRX -February 05, 2024 at 08:33 pm EST

NEW YORK, Feb. 5, 2024 /PRNewswire/  Monteverde & Associates PC , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services.

New yorkUnited statesEmpire state buildingJuan monteverdeMonteverde associatesMa class action firmOld nationalAmbrx biopharma incCapstar financial holdings incRenesas electronics corpTheseus pharmaceuticals incTransphorm incUs supreme courtSecurities class action servicesOld national bancorpConcentra biosciences

Cooley s 2023 Life Sciences M&A Year In Review: Potent Mix Of Creativity And Resilience Spurs Activity Heading Into 2024 - Corporate and Company Law

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024.

United statesBristol myer squibbConcentra biosciencesDechra pharmaBristol myersBristol myers squibbMerck kgaSyneos healthMerck kgaaAmerican association for cancer researchCerevel therapeuticsFederal trade commissionAmerican associationCancer researchOption careRevolution medicines

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.